Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 145572-44-7 Chemical Structure| 145572-44-7

Structure of Sophocarpine monohydrate
CAS No.: 145572-44-7

Chemical Structure| 145572-44-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Sophocarpine, a natural product isolated and purified from the herb of Sophora alopecuroidos L., with anti-viral, anti-cachectic and anti-inflammatory effects, can alleviate liver fibrosis mainly by inhibiting the TLR4 pathway, it may be a potential chemotherapeutic agent for chronic liver diseases, ameliorate the ischemic injury induced by transient focal cerebral ischemia in rats and that this neuroprotective effect may be related to the anti-ASIC1 channel and anti-apoptotic action of sophocarpine, and also alleviate hepatocyte steatosis and the potential mechanism may be the activated signaling pathway of AMPK.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Sophocarpine monohydrate

CAS No. :145572-44-7
Formula : C15H24N2O2
M.W : 264.36
SMILES Code : O=C1C=CC[C@]2([H])[C@@]3([H])CCCN4[C@@]3([H])[C@](CCC4)([H])CN21.[H]O[H]
MDL No. :MFCD26960838

Safety of Sophocarpine monohydrate

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H301
Precautionary Statements:P264-P270-P301+P310+P330-P405-P501
Class:6.1
UN#:2811
Packing Group:

Related Pathways of Sophocarpine monohydrate

PI3K-AKT

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
UM-SCC-47 cells 1 μM, 2 μM, 4 μM 24 hours To evaluate the effect of Sophocarpine on miR-21 expression, results showed that Sophocarpine downregulated miR-21 expression in a dose-dependent manner. PMC5589060
UM-SCC-22B cells 1 μM, 2 μM, 4 μM 24 hours To evaluate the effect of Sophocarpine on miR-21 expression, results showed that Sophocarpine downregulated miR-21 expression in a dose-dependent manner. PMC5589060
LX-2 cells 0.5, 1, and 1.5 mg/ml 6, 12, and 24 hours To evaluate the effect of Sophocarpine on TGF-β1-induced trans-differentiation of LX-2 cells. Results showed that Sophocarpine significantly inhibited the expression of TGF-β1, COL1A, Fibronectin, and TIMP1 in TGF-β1-treated LX-2 cells, indicating its antifibrotic effect. PMC8255064
Bone marrow-derived macrophages (BMM) 0.25, 0.50, 1.00 mM 48 hours Evaluate the effect of SPC on bone resorption, results showed dose-dependent reduction in bone resorption area PMC5825302
Bone marrow-derived macrophages (BMM) 0.31-2 mM 48 or 96 hours Evaluate the effect of SPC on bone resorption, results showed dose-dependent reduction in bone resorption area PMC5825302
Neonatal rat ventricular myocytes 10 μmol/L 3 minutes To study the effects of sophocarpine on sodium current, results showed that sophocarpine significantly inhibited sodium current. PMC4002765
Rabbit sinus node cells 0.1-1 μmol/L To study the effects of sophocarpine on slow response action potentials, results showed that sophocarpine decreased APA and Vmax and prolonged APD. PMC4002765
Guinea pig papillary muscle cells 1-100 μmol/L 8-10 minutes To study the effects of sophocarpine on fast response action potentials, results showed that sophocarpine dose-dependently prolonged APD and ERP and decreased APA and Vmax. PMC4002765
Human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) 2, 10, 50 μM 24 hours To evaluate the effects of sophocarpine on impedance and extracellular field potential (EFP) in cardiomyocytes. Results showed that sophocarpine dose-dependently affected both impedance and EFP, related to disruption of calcium homeostasis and oxidative stress. PMC6330446
Rat aortic endothelial cells (RAECs) 0.0625, 0.125, 0.25, 0.5, 1.0, 2.0 mmol/L 48 hours To evaluate the protective effects of Sophocarpine on AGEs-induced oxidative stress and apoptosis. Results showed that Sophocarpine significantly suppressed AGEs-induced ROS production and apoptosis, restored phosphorylation of MKK3/6 and p38 MAPK, and promoted Nrf2 nuclear translocation and ARE binding activity. PMC5779049

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Nude mice UM-SCC-22B xenograft model Intravenous injection 5 mg/kg Every other day for 21 days To evaluate the inhibitory effect of Sophocarpine on tumor growth in vivo, results showed that Sophocarpine significantly inhibited tumor growth without observable tissue toxicity. PMC5589060
C57BL/6 mice CCl4-induced chronic liver fibrosis model Intraperitoneal injection 7.5 ml/kg Once daily for 3 or 6 weeks To evaluate the therapeutic effect of Sophocarpine on CCl4-induced chronic liver fibrosis. Results showed that Sophocarpine significantly improved liver function and histopathological features, reduced collagen deposition, and inhibited HSCs activation. PMC8255064
Sprague-Dawley rats Titanium particle-induced femoral implant loosening model Intraperitoneal injection 20 mg/kg/day Once daily for 4 or 12 weeks Evaluate the preventive effect of SPC on titanium particle-induced implant loosening, results showed SPC inhibited osteoclast formation, reduced pseudomembrane formation, improved bone-implant contact, and enhanced implant stability PMC5825302
Guinea pigs Isoprenaline-induced arrhythmia model Perfusion 300 μmol/L Single administration, lasting 11-17 minutes To study the effects of sophocarpine on isoprenaline-induced arrhythmia, results showed that sophocarpine reversed arrhythmia and decreased heart rate. PMC4002765
Sprague-Dawley rats AGEs-induced aortic endothelial cell injury model Intraperitoneal injection 40 mg/kg/day Once daily for 10 consecutive days To evaluate the protective effects of Sophocarpine on AGEs-induced oxidative stress and apoptosis in aortic endothelial cells. Results showed that Sophocarpine significantly suppressed AGEs-induced ROS production and apoptosis, restored phosphorylation of MKK3/6 and p38 MAPK, and promoted Nrf2 nuclear translocation and antioxidant enzyme expression. PMC5779049

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.78mL

0.76mL

0.38mL

18.91mL

3.78mL

1.89mL

37.83mL

7.57mL

3.78mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories